Clinical Trials Insight: 700042093
Phase of Trial: Phase I
Latest Information Update: 01 May 2009
At a glance
- Drugs PTX 100 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Kirax Corporation
- 01 May 2009 Status changed from planning to recruiting, according to a Tigris Pharmaceuticals media release.
- 27 Feb 2009 New trial record.